Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
Ticker Information
Ticker
CDTXCompany Name
CIDARA THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQCIDARA THERAPEUTICS INC - Stock Based Compensation Margin Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
CDTX - SB Comp % Historical data
| Date | Revenues | Stock Based Compensation | Stock Based Compensation Margin |
|---|---|---|---|
| 6/30/2025 | $ 0 | $ 7.11M | 0% |
| 3/31/2025 | $ 302K | $ 4.85M | 1606.95% |
| 12/31/2024 | $ 1.27M | $ 3.91M | 306.43% |
| 9/30/2024 | $ 26.35M | $ 3.08M | 11.69% |
| 6/30/2024 | $ 39.07M | $ 3.12M | 8% |
| 3/31/2024 | $ 46.38M | $ 3.22M | 6.93% |
| 12/31/2023 | $ 63.91M | $ 3.06M | 4.79% |
| 9/30/2023 | $ 56.54M | $ 2.9M | 5.14% |
| 6/30/2023 | $ 84.57M | $ 2.95M | 3.49% |
| 3/31/2023 | $ 83.17M | $ 2.83M | 3.41% |
Key Performance Insights, Last 5 Years
- CIDARA THERAPEUTICS INC's latest trailing twelve months (TTM) SB Comp % stands at 42.02%.
- Over the past 5 years, CIDARA THERAPEUTICS INC's average SB Comp % has been 111.81%.
- The median SB Comp % for CIDARA THERAPEUTICS INC during this period was 8.1%
- CIDARA THERAPEUTICS INC reached its highest SB Comp % over the past 5 years at 1606.95%.
- The lowest SB Comp % recorded by CIDARA THERAPEUTICS INC in the same timeframe 3.41%
Similar metrics to SB Comp %:
- Stock Based Compensation - [Cash Flow Statement] Stock Based Compensation, also called Share Based Compensation or Equity Compensation, is a method of paying directors, executives and employees with equity in the business. As non-cash expense, this element is added back when calculating net cash generated by operating activities [NCFO].
- Interest Expense Margin - [Calculation] The company’s interest expenses [IntExp] expressed as a percentage of [Revenue].
- Operating Cash Flow Margin - [Calculation] The company's operating cash flow [NCFO] expressed as a percentage of [Revenue].
- Depreciation and Amortization Margin - [Calculation] The company’s deprecation and amortization [DepAmor] expressed as a percentage of [Revenue].
- Research and Development Margin - [Calculation] The company’s research and development expenses [RnD] expressed as a percentage of [Revenue].
Definition of Stock Based Compensation Margin
[Calculation] The company’s stock-based compensation [SbComp] expressed as a percentage of [Revenue].SB Comp. / Revenues
(=) SB Comp % SB Comp % for CIDARA THERAPEUTICS INC is calculated as follows: SB Comp. [ $ 4.27M ] / Revenues [ $ 10.15M ]
(=) SB Comp % [ 42.02% ] CDTX - Stock Based Compensation Margin, Last 5 years
3.41%
Minimum
Mar 31, 2023
1606.95%
Maximum
Mar 31, 2025
111.81%
Average
8.1%
Median
SB Comp % Benchmark AnalysisMarket
The chart above depicts the distribution of SB Comp % for companies in the Total Stock Market. The average SB Comp % of the companies is 1.72% with a standard deviation of 1.9%.
The following table provides additional summary stats:
SB Comp % in the Market:
| filtered constituents | 2.99K |
|---|---|
| min | -3.97% |
| max | 8.43% |
| average | 1.72% |
| median | 1.04% |
| std | 1.9% |